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This paper aimed to assess quality of colonoscopy reports and determine if physicians in practice were already documenting
recommended quality indicators, prior to the publication of a standardized Colonoscopy Reporting and Data System (CO-RADS)
in 2007. We examined 110 colonoscopy reports from 2005-2006 through Maryland Colorectal Cancer Screening Program. We
evaluated 25 key data elements recommended by CO-RADS, including procedure indications, risk/comorbidity assessments,
procedure technical descriptions, colonoscopy ﬁndings, specimen retrieval/pathology. Among 110 reports, 73% documented the
bowel preparation quality and 82% documented speciﬁc cecal landmarks. For the 177 individual polyps identiﬁed, information
on size and morphology was documented for 87% and 53%, respectively. Colonoscopy reporting varied considerately in the pre-
CO-RADS period. The absence of key data elements may impact the ability to make recommendations for recall intervals. This
paper provides baseline data to assess if CO-RADS has an impact on reporting and how best to improve the quality of reporting.
1.Introduction
Colorectal cancer (CRC) screening reduces CRC incidence
and mortality [1–6]. Major national organizations such as
the United States Preventive Services Task Force (USPSTF),
the American Cancer Society, and the Multi-Society Task
Force on Colorectal Cancer (MSTF-CRC) recommend that
average-risk adults begin CRC screening at age 50 [7, 8]. Any
positive CRC screening test leads to a colonoscopy, which
itself can be a primary CRC screening tool [7, 8]. In the last
few years, utilization of colonoscopy for CRC screening has
increased dramatically [9–11].
The eﬀectiveness of colonoscopy in reducing CRC
incidence and mortality depends on many factors. These
include adequate visualization of the entire colon, diligence
in examining the mucosa, and patient acceptance of the
procedure [12]. Many clinical practice studies have found
variations in colonoscopy quality [13–15] which has become
a concern in the gastroenterology community. In 2002,
the MSTF-CRC published recommendations to improve the
quality and eﬀectiveness of colonoscopy and highlighted key
indicators for continuous quality improvement (CQI) [16].
In order to measure indicators of quality, guidelines for
reporting the indicators need to be in place.
Colonoscopyreportingpracticesarewidelyvariable[17].
Appropriate documentation of the colonoscopy procedure is
an important component of patient care and a key approach
to measure health care quality [17, 18]. Measurement of
quality indicators for colonoscopy reporting can identify
areas for quality improvement [19]. To facilitate such
qualitymeasurementwithinandacrosspractices,theQuality
Assurance Task Group of the National Colorectal Cancer2 Diagnostic and Therapeutic Endoscopy
Roundtable (NCCRT) developed, and in 2007 published, a
standardized Colonoscopy Reporting and Data System (CO-
RADS) [20]. CO-RADS describes the speciﬁc elements for
inclusion in all colonoscopy reports, recommends standard
terms for procedure reporting, and suggests key quality
indicators. Standardized language also facilitates commu-
nication between the endoscopist and the primary care
provider, who is often responsible for referring the patient
for the next surveillance or screening colonoscopy. Similar
standardized reporting and data systems are in place for
both Pap tests (the Bethesda System) and mammography
[21, 22].
To our knowledge, only a few studies have directly
evaluated colonoscopy reporting [17, 19, 23]. Most recently,
Lieberman et al. examined colonoscopy reports from the
73 Clinical Outcomes Research Initiative gastroenterology
practice sites in the United States that used a structured,
computerized endoscopy report generator [19]. The aim of
this paper was to assess the quality of colonoscopy reports
and determine if endoscopists in practice were already
documenting recommended quality indicators, prior to the
publication of CO-RADS. This paper may provide baseline
data to assess if CO-RADS has an impact on reporting and
how best to improve the quality of reporting.
2.MaterialsandMethods
We selected colonoscopy reports for review from a database
containing information related to colonoscopies performed
through Maryland’s Cigarette Restitution Fund Colorectal
Cancer Screening Program. Under this program, in 2005
and 2006, 22 of 24 local health departments (LHDs) oﬀered
CRC screening targeted to Maryland residents who were
50–64 years old, with low income, and uninsured. Eighty-
one percent (81%) of the targeted population in Maryland
resided in these 22 jurisdictions. Most of those jurisdictions
accepted patients with lower-gastrointestinal symptoms such
as abdominal pain, constipation, and blood in stool. LHDs
receive the provider’s routine colonoscopy reports and enter
results into a secure intranet-based database maintained at
the Maryland Department of Health and Mental Hygiene
(MDHMH) for local case management, program statistics,
and quality assurance. Institutional Review Boards at the
MDHMH and the University of Maryland exempted this
study.
Reports eligible for review were from colonoscopies that
were (1) performed from Jan 1, 2005 through Dec 31, 2006,
(2) performed on patients having their ﬁrst colonoscopy in
this program, and (3) had ﬁndings of polyp(s) so that we
could measure as many of the quality indicators as possible
per report. There were 788 eligible colonoscopies with a
ﬁnding of one or more polyps (adenomatous, hyperplastic,
or other type of polyp) during 2005-2006 performed by 110
diﬀerentendoscopists(gastroenterologistsorsurgeons)from
community endoscopy practices: 38 endoscopists performed
1 or 2 procedures that met these criteria, and 72 performed 3
or more procedures. One eligible colonoscopy was sampled
from each of the 110 endoscopists. If an endoscopist is
named on only one eligible colonoscopy report, that report
is reviewed. For those in the database who performed two
or more colonoscopies on program patients, one report was
randomly selected. For each selected colonoscopy, staﬀ at the
MDHMH requested a copy of the colonoscopy report from
the patient medical record maintained at the LHDs. Before
the reports were sent to the MDHMH for analysis, the local
program staﬀ removed all identifying information about
the patient, doctor, and facility. No patient or physician
information could be associated with the reports.
We evaluated 25 of the key data elements recommended
by CO-RADS, including procedure indications, risk and
comorbidity assessments, procedure technical description,
colonoscopy ﬁndings (including polyp characteristics), spec-
imen retrieval, and submission for pathologic examination.
In some reports, the status of specimen retrieval and
submission for pathology were not directly documented, but
were inferred from phrases such as “wait for histopathology,”
“follow up on pathology,” and “follow up biopsy results”.
We created a standardized data form using Microsoft Access
to abstract information on each element. Two investigators,
one from CDC and one from the MDHMH, reviewed
the reports and extracted the data elements independently.
Any diﬀerences between the two abstractors arising during
the extraction process were resolved by consensus of these
two investigators. To determine counts and percentages, we
exported the ﬁnal database into Microsoft Excel and SAS
(version 9.1).
3. Results
The sample of 110 colonoscopy reports from 2005-2006 in
which one or more polyps had been described represented
110 diﬀerent endoscopists from community endoscopy
practices throughout Maryland. We could not assess the
documentation of patient’s age and sex; in an eﬀort to ensure
data anonymity, LHD staﬀ had removed this information
from some reports.
As shown in Table 1, all reports documented the indica-
tion for the procedure; 19% were done for screening where
the patients were cited as being either average or increased
risk; 41% were done for screening where no patient risk
was cited; the remaining 40% were done either for reported
symptoms, family history, as surveillance colonoscopies, or
as followup to an abnormal screening test. The patient’s
medical comorbidities were mentioned in 36% (n = 40) of
the reports, and 15% (n = 16) used American Society of
Anesthesiologists (ASA) classiﬁcation. As shown in Table 2,
the quality of the bowel preparation was noted in 73%
(n = 80) of reports. The quality was described as “excellent,”
“good,” “well prepared”, “poor”, or “inadequate” in 59
reports. Other terms used to describe the bowel preparation
included “fair”, “adequate”, or “suboptimal.” Ten reports
documented the type of preparation used. About 71% of the
reports (n = 78) had speciﬁc sedation medication names; 71
of these included the dose given. The health provider who
administered the sedation was documented in 27 reports,
and anesthesiologists or nurse anesthetists administered the
sedationin22ofthesereports.Onlytwocolonoscopyreports
included no information related to sedation.Diagnostic and Therapeutic Endoscopy 3
Table 1: Counts and percentages of preprocedure data elements included in 110 colonoscopy reports.
Count (n)P e r c e n t a g e ( % )
Informed consent Included 75 68
Not included 35 32
Indication for
colonoscopy
Included 110 100
Average or high risk screening 21 19
Screening, no other indication 45 41
Family history 98
Surveillance 22
Followup to a positive screening test 44
Symptoms 29 26
Not included 00
Risk and comorbidity
Included 40 36
ASA classiﬁcation 16 15
“unremarkable physical exam”, “stable cardiorespiratory system”,
speciﬁed diseases, or refer to other documents
24 21
Not included 70 64
Abbreviations: ASA: American Society of Anesthesiology; RLQ: right lower quadrant.
Table 2: Counts and percentages of data elements for procedural preparations included in the 110 colonoscopy reports.
Count (n)P e r c e n t a g e ( % )
Quality of bowel preparation
Included 80 73
“Excellent,” “good” or “well prepared” 52 47
“Poor” or “inadequate” 7 6
“Adequate” 7 6
“Fair” or “suboptimal” 9 8
“Regular,” “stool” or “left side good” 5 5
Not included 30 27
Bowel preparation type Included 10 9
Not included 100 91
Sedation medication name Included 78 71
Not included 32 29
Sedation medication dose Included 71 65
Not included 39 35
Sedation level Included 17 15
Not included 93 85
Sedation provider Included 27 25
Not included 83 75
Instrument type Included 49 45
Not included 61 55
Instrument number Included 33 30
Not included 77 70
As shown in Table 3, 108 (98%) reports documented
the extent or completeness of the examination. Seventy-nine
(72%) reports documented at least one cecal landmark using
theterms“ileocecalvalve,”“appendicealoriﬁce,”and/or“ter-
minal ileum.” Other terms used solely to describe the intuba-
tion of the cecum included “light in right lower quadrant,”
“landmark,” “anatomic conﬁguration,” or “caput.” Only half
or fewer reports included information about photodocu-
mentation of cecal landmarks, ease of performing the exam-
ination, and retroﬂexion of the endoscope on withdrawal
from the rectum. Three reports documented total procedure
time; one of these documented withdrawal time as well.
There were 177 individual polyps documented among
the 110 reports. Polyp location was documented for all but4 Diagnostic and Therapeutic Endoscopy
Table 3: Counts and percentages of data elements for procedure ﬁndings included in 110 colonoscopy reports.
Count (n)P e r c e n t a g e ( % )
Extent of colonoscopic exam
Included 108 98
Cecum reached 107 97
Cecum not reached 11
Not included 22
Documentation of cecal landmarks
Included 90 82
“Ileocecal valve,” “appendiceal oriﬁce” or
“terminal ileum”
79 72
“Light in RLQ,” “landmark,” “anatomic
conﬁguration” or “caput”
11 10
Not included 20 18
Photodocumentation of landmarks Included 32 29
Not included 78 71
Ease of examination Included 58 53
Not included 52 47
Retroﬂexion Included 51 46
Not included 59 54
Total time Included 33
Not included 107 97
Withdrawal time Included 11
Not included 109 99
one of the individual polyps (Table 4): 82% (n = 145) were
described by anatomic location within the colon, 8% (n =
15) were described by their distance in centimeters from
the anal verge, and 9% (n = 16) were described by both
methods.Ofthe15describedbydistancefromtheanalverge,
three were located in the rectosigmoid segment. Information
on polyp size was provided for 154 (87%) polyps: polyp
size in millimeters or centimeters for 66 polyps, descriptive
terms for 52, and by both methods for 36 polyps. Where
both text and numeric descriptions were used, we found
that diﬀerent physicians did not use the descriptive terms
in the same way. For example, some physicians reported
a 2–5mm polyp as “small,” while others described it as
“diminutive.” Of four polyps measured as 10mm, three were
described as “small,” and the fourth described as “large.”
Polyp morphology was documented for 94 (53%) individual
polyps.Ofthese,theterms“pedunculated,”“sessile,”or“ﬂat”
were used to describe 73 of the polyps. Information on
whetherthepolypwasbiopsiedorremovedwasdocumented
for 174 (98%) polyps; the method of biopsy or removal was
reported for 169 (95%) polyps. The method was described
as “snare with cautery,” “cold biopsy,” “hot biopsy,” and
“fulguration/ablation” for 90 polyps; the method was solely
described as “snare,” “biopsy,” “forceps,” and “cautery” for
the remaining 79 polyps.
4. Discussion
In this study, we looked at 110 colonoscopy reports sampled
from endoscopists in 22 of Maryland’s 24 jurisdictions, for a
time period of 3 to 4 years after publication of the MSTF-
CRC recommendations but before the publication of CO-
RADS. We found that certain key quality indicators were
not consistently well documented by endoscopists in their
colonoscopy reports prior to the publication of CO-RADS
including patient risk and comorbidity, quality of the bowel
preparation, and polyp size and morphology.
CO-RADS recommends use of the ASA classiﬁcation to
document risk and comorbidity [20]. For patients with an
ASA class 3 or higher, colonoscopy should be performed in
a hospital or a setting with full capacity for resuscitation
and support [20]. In our study, almost two thirds of reports
lackedanycomorbiditydocumentation.Only15%ofreports
provided the ASA class. While most patients were seen
for a prescreening or complete physical exam prior to
the endoscopy, where the endoscopist reviews the patient’s
prior history and documents it in the oﬃce record, this
information was not always included in the colonoscopy
report.
It has been reported that interval cancers within 1
to 4 years of screening colonoscopy could result from
missed lesions or incomplete adenoma removal [24]. In fact,
computed tomographic colonography studies have shown
that optical colonoscopy missed 2%–12% of polyps larger
than 10mm [25–27]. Missing lesions may be attributed to
inadequate bowel preparation, an incomplete procedure, or
failure to identify a lesion due to inadequate time spent
examining the colonic mucosa. Inadequate bowel prepara-
tion not only limits the visibility of the mucosa and prolongs
cecal intubation time and withdrawal time, but it also leadsDiagnostic and Therapeutic Endoscopy 5
Table 4: Counts and percentages of data elements described for 177 individual polyps.
Count (n)P e r c e n t a g e ( % )
Location
Included 176 99
By distance only 15 8
By segment only 145 82
By both 16 9
Not included 11
Size
Included 154 87
By number (mm/cm) only 66 37
By descriptive term only 52 29
By both 36 20
Not included 23 13
Morphology
Included 94 53
“Pedunculated,” “sessile”, or “ﬂat” 73 41
“Benign,” “benign and smooth”, or “nonbleeding” 95
“Adenoma-like,” “hyperplastic,” “villous-like,” “polypoid,” “ﬁrm mass,”
“Oblong,” “more raised,” “submucosal”, or “irregular”
12 7
Not included 83 47
Biopsy/removal Included 174 98
Not included 32
Methods
Included 169 95
“Snare w/cautery,” “cold biopsy,” “hot biopsy,” “fulguration” or
“ablation”
90 51
“Snare,” “biopsy,” “forceps” or “cautery” 79 45
Not included 85
Retrieval
a Included 140b 80
Not included 35 20
Pathology
a Included 134C 77
Not included 41 23
a175 polyps were used for percentage calculation because 2 polyps were completely fulgurated.
bInformation on specimen retrieval was inferred for 104 of the 140 individual polyps.
CInformation on specimen submission for pathology was inferred for 95 of the 134 individual polyps.
to a shorter interval for the next exam [12]. Our results
revealed that about 25% of reports lacked any mention of
bowel preparation quality and another 20% of reports used
ambiguous terms to describe the quality. We have heard
anecdotally from some programs that some endoscopists
“chart by exception”, meaning they only mention the quality
of the bowel preparation when it is inadequate. However,
CO-RADS recommends that endoscopists explicitly docu-
ment whether they believe bowel preparation was adequate
to allow the detection of lesions larger than 5mm [20].
Ensuring complete examination of the colon helps
reduce the possibility of missing lesions. All colonoscopy
reports in our study mentioned the extent of the exam-
ination; however, 18% did not provide information on
speciﬁc cecal landmarks. Short withdrawal time may be
associated with detecting fewer adenomas [28]. We found
only one report that documented the withdrawal time.
However, our study period predated the publication of the
associationbetweenwithdrawaltimeandadenomadetection
rates and the subsequent recommendation to document the
withdrawal time in colonoscopy reports.
Polyp characteristics are important factors in assessing
risk for malignancy and recurrence of advanced lesions,
and in determining the follow-up interval [29, 30]. In
this study, size information was absent for 13% of indi-
vidual polyps. In up to one third of individual polyps,
size was described solely with qualitative terms such as
“small” or “large.” Moreover, diﬀerent endoscopists used
diﬀerent qualitative terms to describe same-sized polyps.
CO-RADS recommends reporting polyp size in millimeters.
This facilitates determination of the appropriate interval
for follow-up exams and clear communication between the
endoscopist and the referring physician and patient. While
exact measurement of polyp size during the endoscopy
may be diﬃcult—given that the endoscope contains no
measuring device—many endoscopists use the open biopsy
forceps to estimate polyp size. According to CO-RADS,
polyp morphology should be documented as pedunculated,6 Diagnostic and Therapeutic Endoscopy
sessile, or ﬂat. In our study these speciﬁc morphologic
descriptions were absent for almost half of the identiﬁed
individual polyps, though other descriptors were often used.
It may be that some endoscopists only include morphologic
descriptions for larger polyps where the morphology was
clearly sessile, ﬂat, or pedunculated. Indication of whether
a polyp was completely removed is a key factor to predict the
risk for recurrence of an adenoma and the risk for CRC, and
to set the recall interval. CO-RADS recommends including
this information in the colonoscopy report. However, this
was not always clear in our study. Although “removed”
probably meant “completely removed” in many places, we
recommend that endoscopists assess the completeness of
removal of each polyp (or lack thereof) and clearly state this
in the colonoscopy report.
To our knowledge, only a few studies have directly
evaluated quality in colonoscopy reporting [17, 23]. In 2002,
Robertson et al. assessed quality of colonoscopy reporting by
reviewing a single colonoscopy report from 122 independent
endoscopy centers across the nation [17]. Overall, the quality
of colonoscopy reporting in Robertson’s study was poorer
than what we found in our study. In Robertson’s study,
all colonoscopy procedures were performed on colorectal
cancer patients to detect cancer recurrence [17]. The study
claimed that local customs and template sharing may result
in less variation within and across healthcare facilities [17].
For our study, we used data from colonoscopies performed
throughout a statewide colorectal cancer screening pro-
gram. This program routinely collects available information
on extent of examination, quality of bowel preparation,
and number, size, and type of polyps. LHD may have
emphasized the need for these data elements for program-
patient management over the years. Recently, Lieberman
et al. evaluated the quality of colonoscopy reports in 73
U.S. gastroenterology practice sites that used a structured
computerized endoscopy report generator. In our study,
we analyzed all types of reports, not just those from
computerized report generators. Because of the standard use
of a computerized report generator among the centers in
theconsortium,Lieberman’sstudywasbiasedtowardﬁnding
high rates of completion of quality indicators [19].
The ﬁndings of our study are subject to the following
limitations. First, our study was not population based in
that it did not include every endoscopist in Maryland; it
did, however, include 110 gastroenterologists and surgeons
from throughout Maryland who were contracted in the CRC
screening program. Second, inclusion of only one report per
endoscopist may not adequately represent his/her reporting
quality or the change in quality over time.
Many endoscopists use a reporting tool to generate
their reports. The format and choices in such tools may
not follow CO-RADS and may thus limit the ability of
endoscopists to easily include all the CO-RADS elements.
Also, the lower reporting rate of certain quality indicators on
the colonoscopy report may reﬂect the fact that these items
were routinely recorded in the other parts of the medical
record and not duplicated in the colonoscopy report. The
colonoscopy team includes the endoscopist, anesthetist or
anesthesiologist, and nurses and technicians providing care
to the patient. The patient’s medical history is reviewed by
the endoscopist and anesthesiologist and probably recorded
elsewhere. If an anesthesiologist is administering the seda-
tion, he or she will keep a separate record for the patient’s
chart. Nurses and technicians working in the endoscopy
suite maintain records concerning the documentation of
informed consent, type and upkeep of the endoscope, as
well as specimens that are retrieved and sent to pathology.
Nevertheless, the American Society for Gastrointestinal
Endoscopy (ASGE) guideline published in 1999 suggested
these elements should be included in a single colonoscopy
report [17, 18].
5. Conclusions
This paper provides a snapshot of colonoscopy reporting
in a wide variety of practices that use diﬀerent reporting
systems in pre-CO-RADS period. We observed considerable
variation in reporting of key quality indicators. In some
cases, the absence of key information may complicate a
determination of the appropriate interval for follow-up
exams. Intervals for surveillance which are longer than what
might be recommended based on adequate information on
polyp size, morphology, or completeness of removal may
have a deleterious eﬀect on colorectal cancer prevention.
Intervals which are too short may expose the patient to
unnecessary risk and cost. This paper also provides baseline
data to assess if CO-RADS has an impact on colonoscopy
reporting and how best to improve quality of reporting.
Overall, these data highlight the importance of monitoring
quality indicators in endoscopic practice, with the goal of
improving colonoscopy quality. We encourage endoscopists
toacceptandimplementtherecommendationsofCO-RADS
to achieve this goal.
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